Next |
home / stock / eton / eton message board
Subject | By | Source | When |
---|---|---|---|
$ETON Price now | BioSpecialist | investorshub | 06/22/2023 9:27:54 AM |
The now | BioSpecialist | investorshub | 06/21/2023 4:39:49 PM |
$ETON MomentumIts gaining | BioSpecialist | investorshub | 06/20/2023 5:54:05 PM |
$ETON The gaining up | BioSpecialist | investorshub | 06/20/2023 10:51:26 AM |
Price trading last up | Toddrobertking | investorshub | 06/18/2023 3:15:56 AM |
$ETON Found an interesting article | BioSpecialist | investorshub | 06/16/2023 2:04:26 PM |
Time for this to show some returns | stockguard | investorshub | 06/15/2023 10:28:01 AM |
$ETON bears are running | ClayTrader | investorshub | 06/15/2023 8:51:59 AM |
The now up | XXSPOWER | investorshub | 06/12/2023 3:37:46 PM |
The now | BioSpecialist | investorshub | 06/12/2023 7:13:31 AM |
MomentumIts gaining up | BioSpecialist | investorshub | 06/11/2023 9:57:17 AM |
$ETON The now last trade up | pijoe | investorshub | 06/11/2023 9:42:40 AM |
just the news we needed | ADVFN_bioking | investorshub | 06/08/2023 9:25:37 PM |
$ETON Anyone hear anything lately? Want to see this one go | BioSpecialist | investorshub | 06/08/2023 3:21:25 PM |
Price trading | Glider549 | investorshub | 06/02/2023 6:37:55 PM |
$ETON where is the squeeze? | BioSpecialist | investorshub | 05/31/2023 8:39:02 AM |
$ETON Have a look at this | barnyarddog | investorshub | 05/30/2023 10:08:43 AM |
are we finally gonna see some action | XXSPOWER | investorshub | 05/30/2023 7:25:37 AM |
$ETON Price now | Toddrobertking | investorshub | 05/29/2023 5:52:38 PM |
Eton Pharmaceuticals Announces FDA Approval of ZONISADE (Zonisamide | subslover | investorshub | 07/18/2022 12:11:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Eton Pharmaceutcials Inc. Company Name:
ETON Stock Symbol:
NASDAQ Market:
PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call p...
PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call point Transaction is expected to be accretive to 2024 earnings Estimated peak sales of more than $10 million annually U.S. phenylketonuria ("PKU"...
Q4 2023 revenue of $7.3 million, representing a 109% increase from Q4 2022, marking the twelfth consecutive quarter of sequential product sales growth Full year 2023 revenues reached $31.6 million with product sales and royalty revenues of $26.1 million, a 132% increase from 2022 Announce...